p19 Arf induces p53-dependent apoptosis during Abelson virus-mediated pre-B cell transformation
- 27 October 1998
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 95 (22) , 13194-13199
- https://doi.org/10.1073/pnas.95.22.13194
Abstract
The Ink4a/Arf locus encodes p16Ink4a and p19Arf and is among the most frequently mutated tumor suppressor loci in human cancer. In mice, many of these effects appear to be mediated by interactions between p19Arf and the p53 tumor-suppressor protein. Because Tp53 mutations are a common feature of the multistep pre-B cell transformation process mediated by Abelson murine leukemia virus (Ab-MLV), we examined the possibility that proteins encoded by the Ink4a/Arf locus also play a role in Abelson virus transformation. Analyses of primary transformants revealed that both p16Ink4a and p19Arf are expressed in many of the cells as they emerge from the apoptotic crisis that characterizes the transformation process. Analyses of primary transformants from Ink4a/Arf null mice revealed that these cells bypassed crisis. Because expression of p19Arf but not p16 Ink4a induced apoptosis in Ab-MLV-transformed pre-B cells, p19Arf appears to be responsible for these events. Consistent with the link between p19Arf and p53, Ink4a/Arf expression correlates with or precedes the emergence of cells expressing mutant p53. These data demonstrate that p19Arf is an important part of the cellular defense mounted against transforming signals from the Abl oncoprotein and provide direct evidence that the p19Arf–p53 regulatory loop plays an important role in lymphoma induction.Keywords
This publication has 52 references indexed in Scilit:
- Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and agingOncogene, 1997
- Regulation of p53 stability by Mdm2Nature, 1997
- Mdm2 promotes the rapid degradation of p53Nature, 1997
- Cancer Cell CyclesScience, 1996
- Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindredsHuman Molecular Genetics, 1995
- Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindredsNature Genetics, 1995
- Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibitionNature, 1995
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- Dominant negative MYC blocks transformation by ABL oncogenesCell, 1992
- Requirement for c-ras proteins during viral oncogene transformationNature, 1986